4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-055164
EVP and CFO sold 4,173 shares at an average $578.34 ($2,413,416)
- EVP and CFO acquired 4,173 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dier Mardi EVP and CFO | 2025-12-02 | Option exercise 10b5-1 | +4,173 | $251.63 | $1,050,052 | 14,613 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −320 | $570.39 | $182,524 | 14,293 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −410 | $571.99 | $234,516 | 13,883 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −354 | $573.02 | $202,847 | 13,529 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −717 | $574.00 | $411,559 | 12,812 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −120 | $574.95 | $68,994 | 12,692 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −240 | $576.15 | $138,276 | 12,452 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −320 | $577.81 | $184,901 | 12,132 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −258 | $578.83 | $149,338 | 11,874 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −480 | $579.85 | $278,329 | 11,394 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −240 | $585.44 | $140,505 | 11,154 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −240 | $587.85 | $141,084 | 10,914 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −160 | $589.65 | $94,344 | 10,754 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −160 | $590.37 | $94,460 | 10,594 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −74 | $595.20 | $44,045 | 10,520 | D |
| Dier Mardi EVP and CFO | 2025-12-02 | Sale 10b5-1 | −80 | $596.19 | $47,695 | 10,440 | D |
| Derivatives | |||||||
| Dier Mardi EVP and CFO | 2025-12-02 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,173 | 9,180 | D | ||
| Open-market sales · 4,173 sh · avg $578.34 · $2,413,416 | |||||||
Loading xslF345X05/wk-form4_1764802770.xml…